Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
eyelogic.com

See what CB Insights has to offer

Founded Year

1996

Stage

Asset Sale | AssetsPurchased

About Eyelogic Systems

Eyelogic Systems provides automated refraction eye testing solutions primarily in Canada, the United States, France, and Italy. It operates in two segments, Eyelogic System & Corporate and Investment Structures. The company owns proprietary and patent rights to a software package that allows technicians to perform eyesight testing. It also sells computer and ophthalmic equipment packages, including automated refractors, autorefractors or autorefractors/keratometers, autolensometers, computer equipment, customer hardware interface, and customer interface cabling, as well as its software to opticians, optometrists, eyeglass dispensaries, and other optical related businesses. In addition, the company purchases controlling interests of private companies.

Eyelogic Systems Headquarter Location

140 - 10th Avenue SE Suite 1020

Calgary, Alberta, T2G 0R1,

Canada

Latest Eyelogic Systems News

Eyelogic Systems Announces Sale of Remaining Assets, Distribution to Shareholders and Wind-Up

Dec 2, 2015

CALGARY, ALBERTA--(Marketwired - Dec. 1, 2015) - Eyelogic Systems Inc. ("Eyelogic") (TSX VENTURE:EYE.A)(CSE:EYE.A) announced its intention to wind-up on November 24, 2015. As Eyelogic has now sold its remaining non-cash assets (on the terms set out below), the Board of Directors has resolved to pay a cash dividend of $0.33 per share on December 18, 2015 to all shareholders of record on December 11, 2015 (the "Record Date"). It is anticipated that trading in Eyelogic's shares will recommence on the Canadian Stock Exchange ("CSE") following the dissemination of this press release. However, Eyelogic has requested that its common shares be delisted from the CSE at the close of trading on December 8, 2015 to ensure that no shares are traded ex-dividend. After the shares of Eyelogic have been de-listed from the CSE, no further transfers of shares will be processed by the transfer agent of the Corporation. In order to maximize the cash available for distribution to shareholders, Eyelogic has completed the following two asset sales in an effort to liquidate the remaining non-cash assets of the Company: On December 1, 2015, Eyelogic sold the remaining Canadian eye exam assets for cash proceeds of $200,000 to Mark McDonald (President of Eyelogic). As Eyelogic agreed to pay Mr. McDonald severance of $100,000, the net proceeds received by Eyelogic were approximately $100,000. Given the unique nature of the Canadian eye exam assets and the regulatory requirements, there were only a limited number of potential purchasers and the Board of Directors believes it has received fair value for the assets from Mr. McDonald. On December 1, 2015, Eyelogic sold the remaining public company contracts to Target Capital Inc. (an affiliate of Eyelogic) for cash proceeds of $75,000. Given Target is one of only a limited number of entities that carry on the public controlling shareholder business, there were only a limited number of potential purchasers for the contracts and the Board of Directors believes it has received fair value for the assets from Target. Upon completion of the two asset sales noted above, in addition to the asset sale announced on October, 9, 2015, Eyelogic has available cash of approximately $1,375,000. After paying the dividend of $0.33 per share noted above (being $997,416 in the aggregate), Eyelogic will have approximately $400,000 in cash remaining to satisfy various wind-up costs and expenses (including outstanding litigation liabilities, taxes and costs associated with a final shareholders meeting and transfer agency expenses). The dividend will be funded from Eyelogic's cash reserves, which resu LTE d from the recent asset sales on October 9 and December 1, 2015, rather than cash from continuing operations. The dividend distribution is intended to be a return of capital as the corporation has determined to windup operations and dissolve. The distribution to shareholders by way of return of capital is expected to be generally more advantageous to shareholders than a regular dividend. Shareholders should consult with their professional tax advisor concerning their individual circumstances and are cautioned not to rely on the contents of this email as tax advice. Eyelogic intends on calling a special meeting of shareholders in January 2016 to approve the dissolution of the corporation. In the event that Eyelogic is ultimately successful in dissolving the company and settling ongoing liabilities, taxes and litigation claims, it intends on distributing any remaining amounts at a later date (the amount per share is not expected to be significant). Forward-looking statements Certain statements contained in this press release may constitute forward-looking statements. These statements relate to future events or Eyelogic's future performance. All statements, other than statements of historical fact, may be forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "plan", "continue", "estimate", "expect", "may", "will", "project", "predict", "propose", "potential", "targeting", "intend", "could", "might", "should", "believe" and similar expressions. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Eyelogic believes that the expectations reflected in those forward-looking statements are reasonable but no assurance can be given that these expectations will prove to be correct. Any forward-looking statements included in this press release should not be unduly relied upon by investors as actual results may vary. These statements speak only as of the date of this press release and are expressly qualified, in their entirety, by this cautionary statement. With respect to forward-looking statements contained herein, Eyelogic has made assumptions regarding, among other things: general business and economic conditions in Canada ; fluctuations in interest rates and currency values; changes in monetary policy;

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.